Acute superior vena caval thrombosis after central venous catheter removal: successful treatment with thrombolytic therapy.
The use of central venous catheters for the administration of cancer chemotherapy has become commonplace, but a variety of potential complications related to catheter use have been clinically recognized. We report a patient in whom acute superior vena cava thrombosis developed after removal of a central venous catheter used to administer chemotherapy for breast cancer. Prompt clinical recognition and therapy resulted in resolution of the thrombus, both clinically and radiographically.
Theriault
R L
RL
Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Buzdar
A U
AU
D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000188:drug therapy; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000188:drug therapy; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*; D014683:Vena Cava, Superior
D014568:Urokinase-Type Plasminogen Activator